* Encoding: UTF-8.

DATASET ACTIVATE DataSet1.

#D1 = non-split
#D2 = split by HT and AD
#D3 = split by HT and AHM
#D4 = split by AD and AHM
#D5 = split by AD only

# Codebook to look at the data

CODEBOOK  [n]
  /VARINFO POSITION LABEL TYPE FORMAT MEASURE ROLE VALUELABELS MISSING ATTRIBUTES
  /OPTIONS VARORDER=VARLIST SORT=ASCENDING MAXCATS=200
  /STATISTICS COUNT PERCENT MEAN STDDEV QUARTILES.

#########################################################################################

# Recoding unto binary variables (Transform -> Recode into different variables)

DATASET ACTIVATE DataSet1

RECODE SEX ('F'=1) ('M'=0) INTO sex_rec.
VARIABLE LABELS  sex_rec 'sex_rec'.
EXECUTE.

RECODE cohort_htn ('1. Control'=0) ('2. AD'=1) ('3. Mixed'=-1) ('4. VaD'=-2) 
INTO cohort_rec.
VARIABLE LABELS cohort_rec 'Hypertension cohort group_rec'.
EXECUTE.

RECODE htn ('No'=0) ('Yes'=1) 
INTO htn_rec.
VARIABLE LABELS  htn_rec 'Hypertension ever in life'.
EXECUTE.

RECODE htn_diag ('No'=0) ('Yes'=1) 
INTO htn_diag_rec.
VARIABLE LABELS  htn_diag_rec 'Hypertension diagnosed clinically during life'.
EXECUTE.

RECODE htn_midlife ('No'=0) ('Yes'=1) 
INTO htn_midlife_rec.
VARIABLE LABELS  htn_midlife_rec 'Hypertension in midlife'.
EXECUTE.

RECODE latelife_bp ('No'=0) ('Yes'=1) 
INTO latelife_bp_rec.
VARIABLE LABELS  latelife_bp_rec 'Late-life bp measurements'.
EXECUTE.

RECODE braak_group ('0-II'=0) ('III-IV'=1) ('V-VI'=2) 
INTO braak_group_rec.
VARIABLE LABELS  braak_group_rec 'Braak stage group (0-II, III-IV, V-VI)'.
EXECUTE.

RECODE Infarcts_any ('1'=1) ('.'=0) 
INTO Infarcts_any_rec.
VARIABLE LABELS  Infarcts_any_rec 'Infarcts of any size'.
EXECUTE.

#recoding AHM data

DATASET ACTIVATE DataSet4.
RECODE AHT_anyreason ('No'=0) ('Yes'=1) INTO AHT_anyreason_rec.
VARIABLE LABELS  AHT_anyreason_rec 'antihypertensives - any type for any reason'.
EXECUTE.

RECODE AHT_reason ('No AHT'=-1) ('AHT for HTN'=1) ('not for HTN'=0) INTO AHT_reason_rec.
VARIABLE LABELS  AHT_reason_rec 'antihypertensives - reason if for/not for treatment of HTN'.
EXECUTE.

RECODE SVD_frontal SVD_parietal CAA_frontal CAA_parietal (0=0) (1=1) (2=1) (3=1) INTO 
    SVD_frontal_rec SVD_parietal_rec CAA_frontal_rec CAA_parietal_rec.
EXECUTE.

#########################################################################################
#########################################################################################

#TASK 1: Summary demographic and neuropathological data of the hypertensive and normotensive AD brains

#########################################################################################
#########################################################################################

#Four-way crosstab for sex; AD/Control; HT/Norm; AHT (non-split data)

DATASET ACTIVATE DataSet1

CROSSTABS
  /TABLES=  cohort_AD_control BY sex_rec BY AHT_anyreason_rec BY htn_rec 
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT
  /COUNT ROUND CELL
  /BARCHART.

#To compare HT and conrtol mean age and mean PMD need to split data set (Data->Split Data->htn_rec&cohort_AD_Control)

#PMDELAY and age for HT vs norm and AD vs control split file

DATASET ACTIVATE DataSet2.
#Split by HT and AD

SORT CASES  BY htn_rec cohort_AD_control.
SPLIT FILE LAYERED BY htn_rec cohort_AD_control.
FREQUENCIES VARIABLES=PMDELAY AGE
  /FORMAT=NOTABLE
  /STATISTICS=STDDEV MINIMUM MAXIMUM MEAN MEDIAN
  /ORDER=ANALYSIS.

#PMDELAY and age for HT vs norm and Treated vs untreated split file

DATASET ACTIVATE DataSet3.
#Split by HT and AHT

SORT CASES  BY htn_rec AHT_anyreason_rec.
SPLIT FILE LAYERED BY htn_rec AHT_anyreason_rec.
FREQUENCIES VARIABLES=AGE PMDELAY
  /STATISTICS=STDDEV MEAN MEDIAN
  /ORDER=ANALYSIS.

#########################################################################################

3.1. Is HT more common in AD than in Controls?

DATASET ACTIVATE DataSet1
.
CROSSTABS
  /TABLES=cohort_AD_control BY htn_rec
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW PROP 
  /COUNT ROUND CELL
  /BARCHART.

#80.9 % of AD cases had HT
#81 % of Controls had HT
#Thus, similar amout of HT among AD and Controls.


#########################################################################################
#########################################################################################

#TASK 2: Is there an association between midlife or late-life SBP/DBP and AD?

#########################################################################################
#########################################################################################

#2.1. Tests of association:

#2.1.1.  Is there an overall association between HT and AD?

#Assessing the relationship between two categorical variables = Chi squared test

DATASET ACTIVATE DataSet1

CROSSTABS
  /TABLES=cohort_AD_control BY htn_rec
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ PHI 
  /CELLS=COUNT ROW COLUMN TOTAL 
  /COUNT ROUND CELL.

#X(1) = 0.000, p=0.986
#No statistically significant association between HT and AD 

#2.1.2. Is there a sig association between overall mid-life HT and AD?

CROSSTABS
  /TABLES=cohort_AD_control BY htn_midlife_rec
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ PHI 
  /CELLS=COUNT ROW COLUMN TOTAL 
  /COUNT ROUND CELL.

#X(1) = 2.088, p=0.148
#No statistically significant association between mid-life HT and AD.

#2.1.3. Is there a association between mean mid-life SBP and mean mid-life DBP in AD vs Controls?

#A binomial logistic regression, predicts the probability that an observation falls into one of 
#two categories of a dichotomous dependent variable based on one or more independent variables that can be 
#either continuous or categorical.
#i.e. cohort_AD_control is the dependent variable

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER SBP_midlife_mean
  /CLASSPLOT
  /CASEWISE OUTLIER(2)
  /PRINT=GOODFIT SUMMARY
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER DBP_midlife_mean
  /CLASSPLOT
  /CASEWISE OUTLIER(2)
  /PRINT=GOODFIT SUMMARY
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER SBP_65plus
  /CLASSPLOT
  /CASEWISE OUTLIER(2)
  /PRINT=GOODFIT SUMMARY
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER DBP_65plus 
  /CLASSPLOT
  /CASEWISE OUTLIER(2)
  /PRINT=GOODFIT SUMMARY
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#No statistically significant association between mid-life SBP/DBP or late-life SBP and AD.

#Sig. association between late-life DBP and AD 
#p = 0.003. 
#The model explained 7.3 % (Nagelkerke R2) of the variance in AD and correctly classified 62.1 % of cases.
#Increasing L DBP was associated with an increased presence of AD.
#See single comparison tests for further information

#########################################################################################

#2.2. Single comparison tests

# 2.2.1. Is there a significant difference between mean mid-life SBP and mean mid-life DBP in AD vs Controls?

DATASET ACTIVATE DataSet1.
# Originial, non-split

# Comparing the means of two independent groups (AD vs Control) = t test (using non-split data) or non-paramentric alternative
# Assumptions: Normality 
# Shapiro-Wilk test as our numerical means of assessing normality (or hist or qqplot)
#Data normally distributed if Shapiro test not sig.
#Assumption of homogeneity of variance: levenes test must be non-significant

EXAMINE VARIABLES=SBP_midlife_mean SBP_65plus DBP_midlife_mean DBP_65plus
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

# Mid-life SBP/DBP and late-life SBP normally distributed -> Independent samples t test
#Late-life DBP not normally distributed -> Mann-Whitney test 

T-TEST GROUPS=cohort_AD_control(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean
  /CRITERIA=CI(.95).

#Levenes non sig.
#p=0.904

T-TEST GROUPS=cohort_AD_control(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=DBP_midlife_mean
  /CRITERIA=CI(.95).

#Levenes non sig.
#p=0.901

T-TEST GROUPS=cohort_AD_control(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_65plus
  /CRITERIA=CI(.95).

#Levenes non sig.
#p=0.326

#Assumption for Mann-Whitney U test: equal shape distributions of the dependent variable
#test of homogeneity of variance (same for kruskal wallis) as follows:

EXAMINE VARIABLES=DBP_65plus BY cohort_AD_control
  /PLOT BOXPLOT STEMLEAF SPREADLEVEL(1)
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#Based on Median and with adjusted df: not sig. 
#Thus assumption met (equal distribution) and are able to use Mann U test

NPAR TESTS
  /M-W= DBP_65plus BY cohort_AD_control(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#p=0.015*

#Individuals with AD have SIGNIFICANTLY higher late-life DBP compared to controls (p<0.05). 
#Mean rank AD = 98.05
#Mean rand Control = 79.32
# (U = 2922.500, p = .015).

#Look at AHM to explain this finding.


#########################################################################################
#########################################################################################

#TASK 3: Relationship between AD and AHM

#########################################################################################
#########################################################################################

#Association between AHM and AD

DATASET ACTIVATE DataSet1.

CROSSTABS
  /TABLES=AHT_anyreason_rec BY cohort_AD_control
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL
  /BARCHART.

#Î§2(1)= 44.014, p = 0.000.
#Significant association was found between AD and AHT_anyreason.
#Of cases not treated with any AHM, 78.08 % had AD.
#Of cases  treated with any AHM, 29.37 % had AD.

CROSSTABS
  /TABLES=AHT_nondiuretic BY cohort_AD_control
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL
  /BARCHART.

#statistically significant association
#X(1) = 46.736, p = 0.000
#Of cases not treated with non-diuretic AHM, 69.44 % had AD.
#Of cases  treated with non-diuretic AHM, 20.88 % had AD.

CROSSTABS
  /TABLES=ACEI_ARB BY cohort_AD_control
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL
  /BARCHART.

#statistically significant association
#X(1) = 27.387, p = 0.000
#Of cases not treated with ACEI/ARB, 58.11 % had AD.
#Of cases  treated with ACEI/ARB, 15.69 % had AD.


DATASET ACTIVATE DataSet6.
#Split by htn_rec only

SORT CASES  BY htn_rec.
SPLIT FILE LAYERED BY htn_rec.

DATASET ACTIVATE DataSet1.

CROSSTABS
  /TABLES=AHT_anyreason_rec BY cohort_AD_control
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL
  /BARCHART.

#Î§2(1)= 36.051, p = 0.000.
#Significant association was found between AD and AHT_anyreason.
#Of HT cases not treated with any AHM, 80 % had AD.
#Of HT cases treated with any AHM, 30.19 % had AD.

CROSSTABS
  /TABLES=AHT_nondiuretic BY cohort_AD_control
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL
  /BARCHART.

#statistically significant association
#X(1) = 42.600, p = 0.000
#Untreated: 74.03 % AD
#Treated: 22.62 % AD 

CROSSTABS
  /TABLES=ACEI_ARB BY cohort_AD_control
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL
  /BARCHART.

#statistically significant association
#X(1) = 24.265, p = 0.000
#Untreated: 59.65 % AD
#Treated: 17.02 % AD 

#########################################################################################

3.2. Is HT more likely to be treated in Control than AD?

DATASET ACTIVATE DataSet6.
#Split by htn_rec only

SORT CASES  BY htn_rec.
SPLIT FILE LAYERED BY htn_rec.

CROSSTABS
  /TABLES= cohort_AD_control BY AHT_anyreason_rec
  /FORMAT=AVALUE TABLES
    /STATISTICS=CHISQ 
  /CELLS=COUNT ROW PROP 
  /COUNT ROUND CELL
  /BARCHART.

#Within HT cases, significant association between AHM and AD (X2(1) = 36.051, p = 0.000).
#Of the AD cases with HT, 42.11 % receive AHT.
#Of the Control cases with HT, 87.06 % receive AHT.

CROSSTABS
  /TABLES= cohort_AD_control BY AHT_nondiuretic
  /FORMAT=AVALUE TABLES
    /STATISTICS=CHISQ 
  /CELLS=COUNT ROW PROP 
  /COUNT ROUND CELL
  /BARCHART.

#Within HT cases, significant association between non-diuretic AHM and AD (X2(1) = 46.600, 
p = 0.000).
#Of the AD cases with HT, 25.00 % receive AHT.
#Of the Control cases with HT, 76.47 % receive AHT.

CROSSTABS
  /TABLES=cohort_AD_control BY ACEI_ARB 
  /FORMAT=AVALUE TABLES
    /STATISTICS=CHISQ 
  /CELLS=COUNT ROW PROP 
  /COUNT ROUND CELL
  /BARCHART.

#Within HT cases, significant association between ACEI/ARB treatment and AD (X2(1) = 24.265, 
p = 0.000).
#Of the AD cases with HT, 10.53 % receive AHT.
#Of the Control cases with HT, 45.88 % receive AHT.

LOGISTIC REGRESSION VARIABLES AHT_anyreason_rec
  /METHOD=ENTER cohort_AD_control 
  /CONTRAST (cohort_AD_control)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).



LOGISTIC REGRESSION VARIABLES AHT_nondiuretic
  /METHOD=ENTER cohort_AD_control 
  /CONTRAST (cohort_AD_control)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).



LOGISTIC REGRESSION VARIABLES ACEI_ARB
  /METHOD=ENTER cohort_AD_control 
  /CONTRAST (cohort_AD_control)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).



#########################################################################################

#3.3. Relationship between different AHT and BP

DATASET ACTIVATE DataSet1.
# Originial, non-split

# Comparing the means of two independent groups (AD vs Control) = t test (using non-split data) or non-paramentric alternative
# Assumptions: Normality 
# Shapiro-Wilk test as our numerical means of assessing normality (or hist or qqplot)
#Data normally distributed if Shapiro test not sig.
#Assumption of homogeneity of variance: levenes test must be non-significant

#3.3.1. Comparing mean BP between any AHM and no AHM

EXAMINE VARIABLES=SBP_midlife_mean SBP_65plus DBP_midlife_mean DBP_65plus
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

# Mid-life SBP/DBP and late-life SBP normally distributed -> Independent samples t test
#Late-life DBP not normally distributed -> Mann-Whitney test 

#Assumption for Mann-Whitney U test: equal shape distributions of the dependent variable
#test of homogeneity of variance (same for kruskal wallis) as follows:

EXAMINE VARIABLES=DBP_65plus BY AHT_anyreason_rec
  /PLOT BOXPLOT STEMLEAF SPREADLEVEL(1)
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#Based on Median and with adjusted df: not sig. 
#Thus assumption met (equal distribution) and are able to use Mann U test

T-TEST GROUPS=AHT_anyreason_rec(0 1)
  /MISSING=ANALYSIS
/VARIABLES=SBP_midlife_mean DBP_midlife_mean SBP_65plus
  /CRITERIA=CI(.95). 

#not significant

NPAR TESTS
  /M-W= DBP_65plus BY AHT_anyreason_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#p=0.046*

#Late-life DBP sig. lower if AHM compared to no AHM . 
#Mean rank AD = 107.32
#Mean rand Control = 126.12
# (U = 4446.000, p = .046).

#########################################################################################

#3.3.2. Comparing mean BP between non-diuretic AHM and no AHM

T-TEST GROUPS=AHT_nondiuretic(0 1)
  /MISSING=ANALYSIS
/VARIABLES=SBP_midlife_mean DBP_midlife_mean SBP_65plus
  /CRITERIA=CI(.95). 

#not significant
#Levenes non sig.
#Late-life SBP sig. higher when taking non-diuretic AHM compared to no AHM (p=0.006*)
#AHT: 144.58 Â± 14.176
#No AHT: 139.000 Â± 15.984

NPAR TESTS
  /M-W= DBP_65plus BY AHT_nondiuretic(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non-sig.

#########################################################################################

#Comparing mean BP between ACEI/ARB treatment and no AHM

T-TEST GROUPS=ACEI_ARB(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean DBP_midlife_mean SBP_65plus
  /CRITERIA=CI(.95).
#non sig.

NPAR TESTS
  /M-W= DBP_65plus BY ACEI_ARB(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non-sig.

#########################################################################################
#########################################################################################

#Same thing but within the AD cohort: Is AHT successful in lowering BP?

# Mid-life SBP/DBP and late-life SBP normally distributed -> Independent samples t test
#Late-life DBP not normally distributed -> Mann-Whitney test 

# Comparing mean BP between any AHM and no AHM within the AD cohort

DATASET ACTIVATE DataSet5.
# Originial, non-split

T-TEST GROUPS=AHT_anyreason_rec(0 1)
  /MISSING=ANALYSIS
/VARIABLES=SBP_midlife_mean DBP_midlife_mean SBP_65plus
  /CRITERIA=CI(.95). 

#not significant

NPAR TESTS
  /M-W= DBP_65plus BY AHT_anyreason_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#DBP_65plus (U = 548.5; p = 0.074) = not significant
#AD untreated mean late-life DBP: 83.15 Â± 8.499
#AD treated mean late-life DBP: 80.33 Â± 8.642

#########################################################################################

#3.3.2. Comparing mean BP between non-diuretic AHM and no AHM

T-TEST GROUPS=AHT_nondiuretic(0 1)
  /MISSING=ANALYSIS
/VARIABLES=SBP_midlife_mean DBP_midlife_mean SBP_65plus
  /CRITERIA=CI(.95). 

#not significant

NPAR TESTS
  /M-W= DBP_65plus BY AHT_nondiuretic(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non-sig.

#########################################################################################

#Comparing mean BP between ACEI/ARB treatment and no AHM

T-TEST GROUPS=ACEI_ARB(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean DBP_midlife_mean SBP_65plus
  /CRITERIA=CI(.95).

#Levenes non sig.
#SBP_65plus; p=0.071
#ACEI/ARB: 144.63 Â± 12.946
#none: 140 Â± 16.115

NPAR TESTS
  /M-W= DBP_65plus BY ACEI_ARB(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non-sig.

#########################################################################################
#########################################################################################

#3.1. Association between AHM and AD

#Test of association:
#Model of effect of different types of AHM on risk of AD

DATASET ACTIVATE DataSet1.
#Original, non-split
#AHT are to be compared to No AHM, with No AHM acting as the reference category (who were coded "0"). 
#Therefore, First is chosen (i.e. Indicator(1)).

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER AHT_anyreason_rec 
  /CONTRAST (AHT_anyreason_rec)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#Sig. association between AHT and AD (p = 0.000). 
#The model explained 27.5 % (Nagelkerke R2) of the variance in AD and correctly classified 73.4 % of cases.
# Individuals AHT are 0.117 times as likely to be have AD as untreated individuals.

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER AHT_nondiuretic 
  /CONTRAST (AHT_nondiuretic)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#Sig. association between non-diuretic AHT and AD (p = 0.000). 
#The model explained 29.2 % (Nagelkerke R2) of the variance in AD and correctly classified 73.9 % of cases.
# Individuals with non-diuretic AHT are 0.116 times as likely to be have AD as untreated individuals.

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER ACEI_ARB 
/CONTRAST (ACEI_ARB)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#Sig. association between non-diuretic AHT and AD (p = 0.000). 
#The model explained 18.5 % (Nagelkerke R2) of the variance in AD and correctly classified 64.8 % of cases.
#Individuals with ACEI/ARB treatment are 0.134 times as likely to be have AD as untreated individuals.

#########################################################################################

#Test of association:
#Model of effect of different types of AHM on risk of AD in HT individuals only

DATASET ACTIVATE DataSet6.
#Split by HT only

SORT CASES  BY htn_rec .
SPLIT FILE LAYERED BY htn_rec.

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER AHT_anyreason_rec 
  /CONTRAST (AHT_anyreason_rec)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#Within HT group, sig. association between any AHT and AD (p = 0.000). 
#The model explained 27.9 % (Nagelkerke R2) of the variance in AD and correctly classified 73.3 % of cases.
# HT Individuals with any AHT are 0.108 times as likely to be have AD as untreated individuals.

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER AHT_nondiuretic 
  /CONTRAST (AHT_nondiuretic)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#Within HT group, sig. association between non-diuretic AHT and AD (p = 0.000).
#The model explained 32.3% (Nagelkerke R2) of the variance in AD and correctly classified 75.8% of cases.
# HT Individuals with non-diuretic AHT are 0.103 times as likely to be have AD as untreated individuals.

LOGISTIC REGRESSION VARIABLES cohort_AD_control
  /METHOD=ENTER ACEI_ARB 
/CONTRAST (ACEI_ARB)=Indicator(1)
  /CLASSPLOT
  /PRINT=CORR CI(95)
  /CRITERIA=PIN(0.05) POUT(0.10) ITERATE(20) CUT(0.5).

#Within HT group, sig. association between ACEI/ARB treatment and AD (p = 0.000).
#The model explained 19.9 % (Nagelkerke R2) of the variance in AD and correctly classified 66.5 % of cases.
# HT Individuals with ACEI/ARB treatment are 0.139 times as likely to be have AD as untreated individuals.

#########################################################################################

# 3.4. Were AD cases more likely to have received less effective AHT?

# Were the AD group more likely to have donated their brain in an earlier time when HT was less likely to be treated appropriately? 

DATASET ACTIVATE DataSet5.
#Split by AD only

DESCRIPTIVES VARIABLES=year_death
  /STATISTICS=MEAN STDDEV MIN MAX.

#AD: year of death mean = 2001.64 Â± 8.28
#Control: year of death mean = 2006.85 Â± 11.41

DATASET ACTIVATE DataSet1.
#Original, non-split

NPAR TESTS
  /M-W= year_death BY cohort_AD_control(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#U = 3242, p = 0.000
#Control group sig. later year if death than AD group



#########################################################################################
#########################################################################################

#TASK 4: What is the relationship between HT and markers of disease severity?

#########################################################################################
#########################################################################################

# Comparing the means of two independent groups (HT vs Norm) = t test (using non-split data)
# Assumptions: Normality and Homogeneity of variance: levenes test must be non-significant
# Shapiro-Wilk test as our numerical means of assessing normality (or hist or qqplot)
#Data normal if shapiro non sig.

DATASET ACTIVATE DataSet1.
EXAMINE VARIABLES=AB40insol_fcx AB40insol_pccx AB42insol_fcx AB42insol_fwm AB42insol_pccx 
    AB42insol_pcwm ab_4G8_f ab_4G8_p AT8_F AT8_P
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#All sig. Shapiro i.e. non-normal distribution for all so Mann-Whitney for all

EXAMINE VARIABLES= AB40insol_fcx AB40insol_pccx AB42insol_fcx AB42insol_fwm AB42insol_pccx 
    AB42insol_pcwm ab_4G8_f ab_4G8_p AT8_F AT8_P BY AHT_anyreason_rec
  /PLOT BOXPLOT STEMLEAF SPREADLEVEL(1)
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#Assumption for Mann-Whitney U test: equal shape distributions of the dependent variable
#test of homogeneity of variance (same for kruskal wallis) as follows:
#Based on Median and with adjusted df: must be non-sig.

#AB40insol_fcx AT8_F AT8_P had sig. values

NPAR TESTS
  /M-W= AB40insol_fcx AB40insol_pccx AB42insol_fcx AB42insol_fwm AB42insol_pccx 
    AB42insol_pcwm ab_4G8_f ab_4G8_p AT8_F AT8_P BY htn_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#AÎ² load (%) â frontal in HT compared to normotensive
#HT group highest AÎ² load 
#Non-sig. (U = 3578.500, p = 0.649)

#AÎ² load (%) â parietal in HT compared to normotensive
#Norm group highest AÎ² load 
#Non-sig. (U = 3045.500, p = 0.624)

#Tau (%) load â frontal in HT compared to normotensive
#Norm group highest Tau load 
#Non-sig. (U = 659.000, p = 0.660)

#Tau (%) load â parietal in HT compared to normotensive
#Norm group highest Tau load 
#Non-sig. (U = 511.000, p = 0.533)

#AÎ²40 insoluble in fcx in HT compared to normotensive (p = 0.213)
#AÎ²40 insoluble in precuneus cortex in HT compared to normotensive (p=0.833)
#Both non-sig.

#AÎ²42 insoluble in fcx in HT compared to normotensive  (p = 0.409)
#AÎ²42 insoluble in precuneus cortex in HT compared to normotensive (p = 0.485)
#AÎ²42 insoluble in fwm in HT compared to normotensive (p = 0.456)
#AÎ²42 insoluble in precuneus white matter in HT compared to normotensive (p = 0.024)

#All non-sig. except for AÎ²42 insoluble in precuneus white matter
#AÎ²42 insoluble highest in precuneus white matter in HT (118.21) compared to norm (90.91)*


#########################################################################################

#3.5. Repeat all but with hypertension in mid-life instead of hypertension ever in life

NPAR TESTS
  /M-W= AB40insol_fcx AB40insol_pccx AB42insol_fcx AB42insol_fwm AB42insol_pccx AB42insol_pcwm 
    ab_4G8_f ab_4G8_p AT8_F AT8_P BY htn_midlife_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#All non-sig. except for AÎ² load - parietal
#AÎ² load - parietal highest in norm (75.42) compared to HT (59.31)*
#Tau load parietal, p=0.056 (highest in norm (57.95) compared to HT (45.95))*

#########################################################################################
#########################################################################################

#Comparing markers of disease severity in HT ever in life vs normotensive within the AD cohort

DATASET ACTIVATE DataSet5.
# Originial, non-split

NPAR TESTS
  /M-W= AB40insol_fcx AB40insol_pccx AB42insol_fcx AB42insol_fwm AB42insol_pccx 
    AB42insol_pcwm ab_4G8_f ab_4G8_p AT8_F AT8_P BY htn_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#Within the AD cohort, no sig. differences in markers of disease severity in HT ever in life compared to normotensive.

NPAR TESTS
  /M-W= AB40insol_fcx AB40insol_pccx AB42insol_fcx AB42insol_fwm AB42insol_pccx AB42insol_pcwm 
    ab_4G8_f ab_4G8_p AT8_F AT8_P BY htn_midlife_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#Within the AD cohort, no sig. differences in markers of disease severity in mid-life HT compared to normotensive.


#########################################################################################
#########################################################################################

#4.1.1. Is there any age-related effects on markers of disease severity in the HT vs normotensive group?

DATASET ACTIVATE DataSet1.

EXAMINE VARIABLES=AGE age_onset duration 
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.
  
#AGE and age_onset non sig. i.e. normal distribution and thus t test
#duration sig. i.e. no normal distribrution

NPAR TESTS
  /M-W= duration BY htn_midlife_rec (0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#Durtation: No sig. difference p=0.307

DATASET ACTIVATE DataSet7.
SORT CASES  BY htn_midlife_rec.
SPLIT FILE LAYERED BY htn_midlife_rec.


DESCRIPTIVES VARIABLES=duration 
  /STATISTICS=MEAN STDDEV MIN MAX.

#Mean duration of dementia for mid-life HT = 8.71 Â± 4.16
#Mean duration of dementia for Norm = 9.33 Â± 3.68
#But: only 24 norm vs 49 mid-life HT cases

DATASET ACTIVATE DataSet1.

T-TEST GROUPS=htn_midlife_rec (0 1)
  /MISSING=ANALYSIS
  /VARIABLES=AGE age_onset
  /CRITERIA=CI(.95).

#Age: levenes sig.; equal variances no assumed; p = 0.181
#Mean age of mid-life HT cohort = 80.20 Â± 8.89
#Mean age of norm cohort = 77.27 Â± 12.58
#But: only 41 norm vs 93 mid-life HT cases

#Age of onset: levenes sig.; equal variances no assumed; p = 0.057
#Mean age of HT cohort = 69.33 Â± 9.65
#Mean age of norm cohort = 64.46 Â± 11.01
#But: only 24 norm vs 49 HT cases






#########################################################################################
#########################################################################################

#TASK 5: Is there a relationship between hypertension and a reduction in blood flow in the cerebral cortex and white matter?

#########################################################################################
#########################################################################################

#5.1. Hypertension ever in life compared to normotensive

# Comparing the means of two independent groups (HT vs Norm) = t test (using non-split data)
# Assumptions: Normality and Homogeneity of variance: levenes test must be non-significant
#Check for normal distribution

#5.1.1. VEGF-A

EXAMINE VARIABLES=VEGF_fcx2 VEGF_fwm2 VEGF_pccx2 VEGF_pcwm2 
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#Non-normal distribution for all so Mann-Whitney for all

NPAR TESTS
  /M-W= VEGF_fcx2 VEGF_fwm2 VEGF_pccx2 VEGF_pcwm2 BY htn_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#VEGF-A in fcx in HT compared to normotensive (U= 3854.5; p= 0.154)
#VEGF-A in fwm HT compared to normotensive (U = 4414.5; p= 0.894)
#VEGF-A in parietal cx in HT compared to normotensive (U= 4389; p= 0.926)
#VEGF-A in parietal wm in HT compared to normotensive (U= 4274.5; p= 0.615)

#All non-sig. 

#########################################################################################

#5.1.2. Haemoglobin-adjusted Fibrinogen

EXAMINE VARIABLES=FGA_Hb_fcx FGA_Hb_fwm FGA_Hb_pcx FGA_Hb_pwm
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.
#Non-normal distribution for all so Mann-Whitney for all

NPAR TESTS
  /M-W= FGA_Hb_fcx FGA_Hb_fwm FGA_Hb_pcx FGA_Hb_pwm BY htn_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#Haemoglobin-adjusted Fibrinogen in fcx in HT compared to normotensive
#Haemoglobin-adjusted Fibrinogen in parietal cx in HT compared to normotensive
#Haemoglobin-adjusted Fibrinogen in fwm in HT compared to normotensive
#Haemoglobin-adjusted Fibrinogen in parietal wm in HT compared to normotensive

#All non-sig. 

#########################################################################################

#5.1.3. PDGFRB

EXAMINE VARIABLES=PDGFRB_pccx2 PDGFRB_fwm2 PDGFRB_fcx2 PDGFRB_pcwm2
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#PDGFRB_pccx2 PDGFRB_fcx2 non-sig. i.e. normal distribution
#PDGFRB_fwm2 PDGFRB_pcwm2 non normal distribution

#normal distribution; check levenes, if non sig. then t test

T-TEST GROUPS=htn_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=PDGFRB_pccx2 PDGFRB_fcx2
  /CRITERIA=CI(.95).

#All non-sig. 

#Mann-Whitney

NPAR TESTS
  /M-W= PDGFRB_fwm2 PDGFRB_pcwm2 BY htn_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#All non-sig.
#Frontal white matter 


#########################################################################################

#5.2. Mid-life hypertension compared to normotensive

NPAR TESTS
  /M-W= VEGF_fcx2 VEGF_fwm2 VEGF_pccx2 VEGF_pcwm2 FGA_Hb_fcx FGA_Hb_fwm FGA_Hb_pcx 
  FGA_Hb_pwm PDGFRB_pccx2 PDGFRB_fcx2 BY htn_midlife_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#All non-sig.

T-TEST GROUPS=htn_midlife_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES= PDGFRB_pccx2 PDGFRB_fcx2
  /CRITERIA=CI(.95).

#All non-sig.

#########################################################################################

#5.3. Relationship between HT and a reduction in blood flow in the cerebral cortex and white matter within the AD cohort

DATASET ACTIVATE DataSet5.
#Repeat analysis within the AD group

#HT ever in life 

NPAR TESTS
  /M-W= VEGF_fcx2 VEGF_fwm2 VEGF_pccx2 VEGF_pcwm2 FGA_Hb_fcx FGA_Hb_fwm FGA_Hb_pcx 
  FGA_Hb_pwm PDGFRB_pccx2 PDGFRB_fcx2 BY htn_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

T-TEST GROUPS=htn_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES= PDGFRB_pccx2 PDGFRB_fcx2
  /CRITERIA=CI(.95).

#Within the AD cohort, still all non-sig.

#Mid-life HT

NPAR TESTS
  /M-W= VEGF_fcx2 VEGF_fwm2 VEGF_pccx2 VEGF_pcwm2 FGA_Hb_fcx FGA_Hb_fwm FGA_Hb_pcx 
  FGA_Hb_pwm PDGFRB_pccx2 PDGFRB_fcx2 BY htn_midlife_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#All non-sig.

T-TEST GROUPS=htn_midlife_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES= PDGFRB_pccx2 PDGFRB_fcx2
  /CRITERIA=CI(.95).

#5.4. Differences in CBF between mid and late-life.

CROSSTABS
  /TABLES=htn_rec BY htn_midlife_rec
  /FORMAT=AVALUE TABLES
    /STATISTICS=CHISQ 
  /CELLS=COUNT ROW PROP 
  /COUNT ROUND CELL
  /BARCHART.

#########################################################################################
#########################################################################################

#4.3. Relationship between CAA and SVD and (mid-life HT) within the AD cohort.

DATASET ACTIVATE DataSet1.

CROSSTABS
  /TABLES=htn_rec htn_midlife_rec BY SVD_frontal SVD_parietal CAA_frontal CAA_parietal
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL.
#Scores

CROSSTABS
  /TABLES=htn_rec htn_midlife_rec BY SVD_frontal_rec SVD_parietal_rec CAA_frontal_rec 
    CAA_parietal_rec
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL.
#Binary variable


#no statistically significant association between HT ever in life or mid-life HT and CAA/SVD; 

#ANOVA Assumption: normal distribution of residuals

DATASET ACTIVATE DataSet5.

CROSSTABS
  /TABLES=htn_rec htn_midlife_rec BY SVD_frontal SVD_parietal CAA_frontal CAA_parietal
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL.
#Scores

CROSSTABS
  /TABLES=htn_rec htn_midlife_rec BY SVD_frontal_rec SVD_parietal_rec CAA_frontal_rec 
    CAA_parietal_rec
  /FORMAT=AVALUE TABLES
  /STATISTICS=CHISQ 
  /CELLS=COUNT ROW ASRESID 
  /COUNT ROUND CELL.
#Binary variable

##############################################################################

#6.1. Differences in mean BP between Frontal/Parietal SVD/CAA and control within the AD cohort

#6.1.1. Binary variable 

#Frontal SVD within the AD cohort

DATASET ACTIVATE DataSet5.

#Binary variable and thus independent samples t test

EXAMINE VARIABLES=SBP_midlife_mean SBP_65plus DBP_midlife_mean DBP_65plus
  /PLOT BOXPLOT NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

# Mid-life SBP/DBP and late-life DBP normally distributed -> Independent samples t test
#Late-life SBP not normally distributed -> Mann-Whitney test 

T-TEST GROUPS=SVD_frontal_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean DBP_midlife_mean DBP_65plus
  /CRITERIA=CI(.95).

#Equal variances not assumed (p=0.0120): 
#Statistically significant difference in the mean mid-life DBP between the 
#frontal SVD group (81.76 Â± 8.376) and the control group (79.14 Â± 7.515) 
#(t(26.202)=-2.060, p=.049.)


NPAR TESTS
  /M-W= SBP_65plus BY SVD_frontal_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non sig.

#######################################

#Parietal SVD within the AD cohort

T-TEST GROUPS=SVD_parietal_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean DBP_midlife_mean DBP_65plus
  /CRITERIA=CI(.95).

#non sig.

NPAR TESTS
  /M-W= SBP_65plus BY SVD_parietal_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non sig.


#######################################

#Frontal CAA within the AD cohort

T-TEST GROUPS=CAA_frontal_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean DBP_midlife_mean DBP_65plus
  /CRITERIA=CI(.95).

#non sig.

NPAR TESTS
  /M-W= SBP_65plus BY CAA_frontal_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non sig.

#######################################

#Parietal CAA within the AD cohort

T-TEST GROUPS=CAA_parietal_rec(0 1)
  /MISSING=ANALYSIS
  /VARIABLES=SBP_midlife_mean DBP_midlife_mean DBP_65plus
  /CRITERIA=CI(.95).

#non sig.

NPAR TESTS
  /M-W= SBP_65plus BY CAA_parietal_rec(0 1)
  /STATISTICS=DESCRIPTIVES QUARTILES
  /MISSING ANALYSIS.

#non sig.

##############################################################################

#6.1.1. Categorical variable (3 categories) 

#Frontal SVD

#Create the residuals (using original data set):

DATASET ACTIVATE DataSet5.

UNIANOVA SBP_midlife_mean DBP_midlife_mean SBP_65plus DBP_65plus BY SVD_frontal
  /METHOD=SSTYPE(3)
  /INTERCEPT=INCLUDE
  /SAVE=RESID
  /CRITERIA=ALPHA(0.05)
  /DESIGN=SVD_frontal.

EXAMINE VARIABLES=RES_1 RES_2 RES_3 RES_4
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#Residuals for SBP_65 plus not normally distributed -> KruslaL Wallis

ONEWAY SBP_midlife_mean DBP_midlife_mean DBP_65plus BY SVD_frontal
  /STATISTICS DESCRIPTIVES HOMOGENEITY WELCH 
  /MISSING ANALYSIS
  /POSTHOC=GH ALPHA(0.05).

#No levenes could not be computed: You should run Welchâs test in all cases where you have normally 
#distributed data that violates the assumption of homogeneity of variance. 

#Non sig.

NPAR TESTS
  /K-W= SBP_65plus BY SVD_frontal(0 3)
  /STATISTICS DESCRIPTIVES 
  /MISSING ANALYSIS.

#Non sig.
#No statistically significant difference in BP between the different SVD scores.

#######################################

#Parietal SVD

#Create the residuals:

DATASET ACTIVATE DataSet5.
UNIANOVA SBP_midlife_mean DBP_midlife_mean SBP_65plus DBP_65plus BY SVD_parietal
  /METHOD=SSTYPE(3)
  /INTERCEPT=INCLUDE
  /SAVE=RESID
  /CRITERIA=ALPHA(0.05)
  /DESIGN=SVD_parietal.

EXAMINE VARIABLES= RES_5 RES_6 RES_7 RES_8
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#All normally distributed

ONEWAY SBP_midlife_mean SBP_65plus DBP_midlife_mean DBP_65plus BY SVD_parietal
  /STATISTICS DESCRIPTIVES HOMOGENEITY WELCH 
  /MISSING ANALYSIS
  /POSTHOC=GH ALPHA(0.05).

#No levenes could not be computed
#You should run Welchâs test in all cases where you have normally distributed data 
#that violates the assumption of homogeneity of variance. 

#When you use Welchâs ANOVA, you can use the Games-Howell multiple comparisons method.

#Welch ANOVA: Statistically significant difference in the mean late-life DBP between the 
#parietal SVD group (82.86 Â± 8.410) and the control group (79.14 Â± 3.078) (F(3,18.531) = 3.155, p = .049). 

#A Games-Howell post hoc test revealed that late-life DBP was statistically significantly lower for 
frontal CAA score 0 (78.18 Â± 7.427, p = .042) compared to score 3 (87.40 Â± 4.506). 


#######################################

#Frontal CAA

#Create the residuals:

DATASET ACTIVATE DataSet5.
UNIANOVA SBP_midlife_mean DBP_midlife_mean SBP_65plus DBP_65plus BY CAA_frontal
  /METHOD=SSTYPE(3)
  /INTERCEPT=INCLUDE
  /SAVE=RESID
  /CRITERIA=ALPHA(0.05)
  /DESIGN=CAA_frontal.

EXAMINE VARIABLES= RES_9 RES_10 RES_11 RES_12
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#All normally distributed

ONEWAY SBP_midlife_mean SBP_65plus DBP_midlife_mean DBP_65plus BY CAA_frontal
  /STATISTICS DESCRIPTIVES HOMOGENEITY WELCH 
  /MISSING ANALYSIS
  /POSTHOC=GH ALPHA(0.05).

#No levenes could not be computed
#You should run Welchâs test in all cases where you have normally distributed data 
#that violates the assumption of homogeneity of variance. 

#Non sig.

#######################################

#Parietal CAA

#Create the residuals:

DATASET ACTIVATE DataSet5.
UNIANOVA SBP_midlife_mean DBP_midlife_mean SBP_65plus DBP_65plus BY CAA_parietal
  /METHOD=SSTYPE(3)
  /INTERCEPT=INCLUDE
  /SAVE=RESID
  /CRITERIA=ALPHA(0.05)
  /DESIGN=CAA_parietal.

EXAMINE VARIABLES= RES_13 RES_14 RES_15 RES_16
  /PLOT BOXPLOT STEMLEAF NPPLOT
  /COMPARE GROUPS
  /STATISTICS DESCRIPTIVES
  /CINTERVAL 95
  /MISSING LISTWISE
  /NOTOTAL.

#All normally distributed

ONEWAY SBP_midlife_mean SBP_65plus DBP_midlife_mean DBP_65plus BY CAA_parietal
  /STATISTICS DESCRIPTIVES HOMOGENEITY WELCH 
  /MISSING ANALYSIS
  /POSTHOC=GH ALPHA(0.05).

#No levenes could not be computed
#You should run Welchâs test in all cases where you have normally distributed data 
#that violates the assumption of homogeneity of variance. 

#Non sig.

